Cargando…
Identification of Potential Biomarkers for Cancer Cachexia and Anti-Fn14 Therapy
SIMPLE SUMMARY: Cancer cachexia is an underestimated condition with huge impact on survival and quality of life for many cancer patients. Currently, there is no reliable diagnosis for this condition, particularly for cancer cachexia at an early stage. The aim of our study is to develop potential bio...
Autores principales: | Cao, Zhipeng, Burvenich, Ingrid J., Zhao, Kening, Senko, Clare, Glab, Jason, Fogliaro, Renee, Liu, Zhanqi, Jose, Irvin, Puthalakath, Hamsa, Hoogenraad, Nick J., Osellame, Laura D., Scott, Andrew M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688504/ https://www.ncbi.nlm.nih.gov/pubmed/36428623 http://dx.doi.org/10.3390/cancers14225533 |
Ejemplares similares
-
Biomarkers for Cancer Cachexia: A Mini Review
por: Cao, Zhipeng, et al.
Publicado: (2021) -
BH3-only proteins: the thorny end of the ER stress response
por: Glab, Jason A, et al.
Publicado: (2017) -
Chemical chaperone TUDCA prevents apoptosis and improves survival during polymicrobial sepsis in mice
por: Doerflinger, Marcel, et al.
Publicado: (2016) -
Alpha-Ketoglutarate Regulates Tnfrsf12a/Fn14 Expression via Histone Modification and Prevents Cancer-Induced Cachexia
por: Ruiz, Bryan I., et al.
Publicado: (2023) -
TWEAK and Fn14 in the Neurovascular Unit
por: Yepes, Manuel
Publicado: (2013)